Pradaxa · DIN 02312441 · 110 mg · capsule
General benefitMarketed · checked November 19, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Pradaxa · DIN 02312441
Manufacturer: Boehringer-Ingelheim (Canada) Ltd./Ltee; listing date 2012-04-24
Health Canada: Marketed since 2008-07-03 · brand PRADAXA · ATC B01AE07 DABIGATRAN ETEXILATE · form Capsule · route Oral · ingredients DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 110 MG · company Boehringer ingelheim (canada) ltd ltee · schedule Prescription
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02312441)
Source record
DIN 02312441: Pradaxa
Raw flags: sec3=Y
Item: 201200084; group id 252; item number 0446; lccId None; manufacturer id BOE
Source form: Cap; strength: 110mg
Recorded listing: General benefit
Source prices (unrounded): $1.8060; ministry $1.2540
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02312441
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=79795
Interchangeable products
Apo-Dabigatran · DIN 02468905 · $1.2540
Shortage status: not checked (no credentials)